Furthermore, miR-148a represses HIF-1α/VEGF and Mcl-1 by directly targeting ROCK1/c-Met, thereby diminishing angiogenesis and enhancing apoptosis in colon cancer cells. Here, HIF1A is linked to colonic neoplasm.